These insights suggested that the early-stage C0 IGLC3+ cells, with their high stemness, could be crucial for tumor initiation, while the later-stage C3 cells, enriched for oxidative stress regulation, might play a role in tumor progression and resistance to treatment. This evidence concerns the gene IGLC3 and neoplasm.